Abstract. The 
glucose in the perfused pancreas of the rat was investigated. Inhibition of glucagon secretion by a high glucose concentration (22 mM) was attenuated and delayed when tested 20 min after a previous infusion with the same glucose concentration. Previously elevated glucose also delayed for 2 min a glucagon response to glucose omission whereas the total response was not significantly affected. During a 20 min perfusion with 1 mM iodoacetate, glucagon secretion increased and rates of secretion were further augmented after withdrawal of iodoacetate. When introduced 10 min after cessation of the iodoacetate pulse, 22 mm glucose failed to affect insulin or somatostatin release but, conversely, induced a profound decrease in glucagon secretion which was more marked than during control conditions. Conclusions: A-cell sensitivity to glucose is diminished and enhanced by prior fuel abundance and deprivation, respectively. Such effects could be due to persisting changes in A-cell energy availability rather than to pertubations in insulin or somatostatin secretion.
Glucose profoundly influences all aspects of gluca¬ gon secretion; elevation of ambient glucose inhibits basal as well as stimulated release while opposite changes are induced by a decrease in glucose concentration (review Gerich et al. 1976 (Efendic et al. 1980 ).
We have previously demonstrated that a 'mem¬ ory' of previous exposure to glucose influences stimulation of glucagon secretion by arginine (Grill et al. 1979 (Faloona & Unger 1974) using 30 antibodies obtained from Dr. Unger, Dallas, Texas. The sensitivity was about 10 pg/ml and the inter-assay coefficient of variation ± 7%.
Insulin was assayed radioimmunologically using char¬ coal addition to separate free and bound antibody (Her¬ bert et al. 1965 ). The sensitivity of this assay was 8 pU/ml and the inter-assay coefficient of variation ±10%. Soma¬ tostatin was assayed as described (Efendic et al. 1979) using [125I]Tyr1-somatostatin-14 and our own antibodies (R141E). The sensitivity of the somatostatin assay was about 2 pg/ml and the inter-assay coefficient of varia¬ tion ± 15%.
Presentation of results
All results were expressed as mean ± se. Levels of sig¬ nificance were calculated using Student's i-test 
Results
Effects ofprevious glucose on suppression ofglucagon secretion by elevated glucose As expected, glucagon secretion was depressed when the glucose concentration in the perfusion medium was changed from 3.9 to 22 mM glucose (Fig. 1) (Fig. 4) priming effect on B-cell secretion is well docu¬ mented and characterized (Cerasi 1975; Grill et al. 1978) . A priming effect on D-cell secretion is less general and/or profound. We observed a small enhancing effect on arginine-induced somatostatin secretion . However, when glu¬ cose-primed pancreases were again stimulated with the hexose, a priming effect was observed in one study (Kanatsuka et al. 1981) but not in another (Gerber et al. 1984) and not in the present study. The present study investigated a priming effect of glucose on -cell secretion. A 'memory' of glucose has been shown to inhibit subsequent argi¬ nine-induced glucagon secretion in vitro (Grill et al. 1979 (Fig. 3) and since the effects of 22 mM glucose on glucagon secretion in control experiments of Fig. 4 were comparable to that of the first glucose pulse of Fig. 1 (Grill et al. 1979 Observations showing augmented ATP-levels 30 min after a pulse of elevated glucose (Grill & Âgren 1980) (Sener et al. 1978 ).
In other respects our results confirm several known effects of iodoacetate, such as inhibition of glucose-induced insulin secretion (Sener et al. 1978) and enhancement of glucagon secretion dur¬ ing the presence of iodoacetate (Edwards & Taylor 1970) and persisting inhibition of glucose-induced insulin secretion (Zawalich et al. 1977) 
